NCT05339906

Brief Summary

In this study, the investigators will research the efficacy of a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 25, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 31, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 21, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

April 21, 2022

Status Verified

April 1, 2022

Enrollment Period

1.5 years

First QC Date

March 31, 2022

Last Update Submit

April 15, 2022

Conditions

Keywords

Speech disordersBinaural beatsAuditory stimulationStutteringStammering

Outcome Measures

Primary Outcomes (1)

  • Speech disfluencies

    The total number of repetitions, blocks and prolongations during the speech (assessed by speech therapist) measured before, just after and 10 minutes after auditory stimulation

    The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

Secondary Outcomes (6)

  • Heart Rate Variability Stress Index [a.u.]

    The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  • Heart Rate Variability meanRR [ms]

    The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  • Heart Rate Variability Total Power [ms^2]

    The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  • Heart Rate Variability SDNN [ms]

    The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  • Heart Rate Variability RMSSD [ms]

    The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  • +1 more secondary outcomes

Study Arms (1)

ZOV.ai digital therapy candidate

EXPERIMENTAL

The arm will use a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes to improve stuttering symptoms. The total length of the audio stimuli is 5 minutes.

Device: ZOV.ai digital therapy candidate

Interventions

ZOV.ai is a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes to improve stuttering symptoms

ZOV.ai digital therapy candidate

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with stuttering (stammering) symptoms;

You may not qualify if:

  • Hearing disabilities;
  • Applying other drugs or devices simultaneously;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oles Honchar Dnipro National University

Dnipro, Dnipropetrovska, 49010, Ukraine

RECRUITING

MeSH Terms

Conditions

StutteringSpeech Disorders

Condition Hierarchy (Ancestors)

Language DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dmytro Lituiev, PhD

    SynthezAI Corp.

    STUDY CHAIR

Central Study Contacts

Dmytro V Chernetchenko, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Audio intervention with the same stimulus for participants with and without stuttering
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Associate Professor

Study Record Dates

First Submitted

March 31, 2022

First Posted

April 21, 2022

Study Start

May 25, 2021

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

April 21, 2022

Record last verified: 2022-04

Locations